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Mutant proteins (muteins) of human lnterleukin-4 (llA) were constructed by means of in vitro mutagenesis. The muteins were expressed in E. co/1, 
submitted to a renaturation and purification protocol and analysed for biological activity. Exchange of the cysteines at either position 46 or 99 
which form one of the three disulfide bridges resulted. in a nearly co•mplete loss · of biological actiyity and an unstable protein. The exchange of 
tyrosine 124 also inactivated the protein, while a mutation of tyrosine 56 left some residual activity. Exchange of the other four cysteines or of 
· the single tryptophane had smaller etTects. ·. · 
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1. INTRODUCTION 
lnterleukin-4 (IL4) is one of the many cytokines 
which induce and coordinate the proliferation, matura-
tion, · survival and differentiation of lymphoid and 
myeloid cells (for reviews see [1-3]). In pardcular, IL4 
. functions in lgE~mediated immune responses, and pro-
motes directly the proliferation of thymocytes and ac- · 
tivated T~cells. A high affinity .IL4 receptor protein of 
· Mr 140 000 has beeri identified, which consists of 800 
amino acid residt~es according to the cDNA sequence 
[4]. It belongs to a recently described group of recep-. 
tors, designated as hematopoietin receptor superfamily 
[5). . . 
The amino acid sequence of mature human IL4 a$ 
· deduced from the cloned· cDNA [6] consists of ··129 
residues. The cDNA has been expressed in E. coli [7 ,8] 
and yeast {9]. From these sources recombinant IL4 with 
high biological activity has been prepared. Circular 
dichroisril arid ·protein-chemical experiments with 
motise and human IL4 have been reported that revealed 
some properties of .the aromatic amino acid residues 
[10, i2] as wel as the pairing of the six cysteines in three 
disulfide bridges [11 ,13J. In the present study the same 
amino acid residues of human IL4 were exchanged by in 
vitro mutagenesis in or~er to analyse their significance 
for structure an~ flinction of the protein. . 
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2. MATERIALSAND METHODS 
An EcoRV I BamHJ fragment encoding the major part of mature 
human lnterleukin-4 was excised from an engineered cDNA. (British 
Bio-techrioiogy Ltd., Oxford, England). This DNA fragment together 
with synthetic oligonucleotides S'~CATGCACAAGTGCGAT and 
S '-ATCGCACTTGTG, cornprising the first 4 amino acid codons of 
lnterleukin-4 plus the codon for methionine, were inte~rated between 
the Ncol and BamHl sites of expression vectm· RT pRC109 (14]. 
Oligonucleotidc-directecl mutagenesis was performed by the gapped 
duplex DNA approach [14,15]. The final construct of the mutated 
· cDNA was seq\)enced artd after confirmation of the specific change 
the straln was used for expression of the mutant protein. . 
Recombinant human lnterleukin-4 (rli1L4) and JL4 muteins were 
isolated essentlally as described by Kato et al. [16] with modifications 
detailed elsewhcre (14]. All fractions obtained after CM-Sepharose 
chroinatography and after HPLC were analysed by dodecylsulfate 
·. polyacrylamide·gel electrophoresis ( 17). Protein concentration was 
determined by absorbance at 280 nm (I mg ll4/ml was assumed to 
yield an absorbance at 280 nm of 1). Proper corrections were made in 
the case of variants missing.tryptophane or tyrosine [18}. 
Thc amount of IL4 in the. 'inclusion body' fraction was estimatr.d 
by co·electrophoresis of these fractions and defined amounts of pure 
rhlL4 and subsequent densltometric determlnation of bound 
Coomassie bluc stain. Proliferative activlties weredetermine.d by 
measuring in duplicate the 1L4-depcndent incorporation of 
·( 3H]thymidine irtto pc=ripheral blood lyniphocytes preactivated for 7 
day~ with phytohemagglutinine [6}. 
3. RESULTS AND DISCUSSION 
. . 
. Tlie rhiL4 protein is expressed with reasonable effi-
ciency (15-20% of whole cell protein; Fig~ lA) in the 
constructed E. ·coli süahis employing the right pro- · 
· motor of phage Iambda and temperature-sensitive 
·Iambda · reprcssor ~ogether with the z·ibosome binding 
site of the E. coli atpE cistron [19). Comparable results 
are ·. obtainccl when the same ribosenie binding site is 
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Fig. 1. Purification of recombinant human· lnterleukin-4 from an 
overproducing E. coli strain. Whole cellular proteins [a), soluble pro-
teins [b], inclu.sion bodies [c), combined fractions. after. CM-. 
Sepharose chromatography (d] and after HPLC [e)were submitted to 
dodecylsulfate-gel electrophoresis ~n~ · visualized •. by staining. with 
· Coomassie brilliant blue R-250 .. 
useci together with a synthetic promotor from phage TS. 
and the operatur/repr~ssor system from the lac operon 
[20]. As demonstrated in Fig~ 1C the recombinant pro- · 
tein is concentrated in the particulate fraction of the E. 
coli homogenate (60-SOOJo of total protein). Compared 
to sedimented 'inchision bodies' of other recombinant · 
cytokines, e.g. of 1L2 [14], the IL4-containing sedimi::mt • 
exhibited a more fluffy and greenish appearance. After 
· renaturation of the 6 M-guanidiniumchloride-dissolved 
. protein the rhiL4was eluted af 0.35-0.4 M Na CI from 
the CM-Sepharose column recovering 20-300Jo of iL4 
present in the 'inclusion bodies;. During HPLC over a 
C4 column the rhiL4 eluted at 40-42% acetonitrile. The 
final yield was 1-2 mg IL4 per 1 of original E. coli 
cultu~e with a purity better than 9SOJo. The specific 
biological activhy as measured by the halfmaximal pro-
liferative response of. human T-cells amounted · to 
0.2-0.S x 106 U/mg proteiri. 
The six cysteine codons in the IL4 cDNA have been 
singly replaced by a threonine .codon in order to pro-
duce muteins C3T, C24T, C46T, C6ST, C99T and 
C127T. The side chain of threonine has a surface area 
only slightly larger than that of cysteine (21]. Each of 
the six mutant proteins could be isolated.and purified. 
In the case of C46T very low yields were observed; 
Re~analysis of the purified variants by HPLC reveal-
. ed multiple species with C46T arid C99T. Apparently, . 
. . 
. . . 
subsitution ofthe cysteines at either position 46 or 99 by 
· threonine rendered the protein unstable. Proliferative 
· activity with C46T and C99T was less than ·1 OJoof.wild-
. type activity (Fig. 2). Replacement of cysteines in C3T, 
C24T, C6ST and C 127T reduced the biological activity 
to some extent. Specific activities 3-5 times lower than 
· in the normal IL4 were measured. · The s.ix cysteine 
. residues in rhiL4 have been assigned to thn!e disulfide 
bridges [11,13]. Most .interestirigly, the cysteines at 
positions 46 and 99 form one disulfide bridge which ac-
cording to the results above is essential for structure a.nd 
function. The disulfide bridges formed between cys-
teines 3 and 127. as weil as between cysteines 24 and 65 
seem to be less lmportant for structural integrity. 
'lnclusion bodies' from IL4 wild-type and mutant 
strains could be assayed directly for biological activity 
by diluting solution~ of. proteins denaturated in . 
· guanidiniumchloride or dodecylsulfate buffers into the 
. T-cell culture medium (RPMI/10% fetal calf serutri). 
Specific activities were measured in the order IL4 wild-
type > C3T- C24T- C6ST- C127T > C46T- C99T .. 
Theseare the same relations as found with the purified 
· proteins (Fig. 2), even though the absolute values were 
about 20-fold (guanidiniumchloride buffer) or 100-fold 
(dodecylsulfate buffer) lower. · · 
. Recently, biophysical and protein-chemical studies 
.on the, aromatic side chains of human IL4 have been 
reported [10,12]. We have singly· replaced the .two 
tyrosines by aspartic acid and the · tryptophane by · 
arginfne, yielding the muteins YS6D, 1240 and W91R. 
Despite these drastic changes affecting size, polarity 
and charge of the particularside chains, these three mu-· 
teins could be purifled in yields comparable to wild-type 
I L4. Replacing the aromatic side chains Iead to the ex-
pected changes ofthe absorbance spectrum in the near · 
UV. During re-analysis by HPLC all three muteins were 
eluted as singie peaks at an unchanged acetonitrile con-
centration. This suggests that the structure was not im-
paired to a major extent by these amino acid exchimges. 
Interestingly, W91R · showed an unchanged or even 
moderately enhanced specific proliferative activity (Fig. 
2). According to drcular dichroism rn:easurements the 
tryptophane is largely accessible to the solvent ,[12]. It. is · 
· also easily modified by N-bromosuccinimide [10]. ln 
mouse IL4 the position of tryptophane 91 appears tobe 
·also occupied by an arginine [11]. Thus it is conceivable. 
that • the human IL4 mutein W91 R exhibits full 
biological activity. It has to be noted, however, that 
chemical modification reduces biological activity [lOJ. 
. The Y 1240 mutein ·.was completely inactive, while · 
Y56D retainecl S-lOOfo of the wild-type activity. 
Tyrosine 124 but not 'tyrosine 56 is ea$ily modified by 
tetranitromethane [lOJ. Accordingly, tyrosine 124 is 
· probably· exposed at the proteiri surface. The activity is . 
·• orily marginally reduced by this chemical modification. · 
8oth .ty.rosines are conserved between human and 
mouse IL4. Mutein Y124D .where tyrosine 124 is 
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Fig. 2. Speclfic proliferative acÜvities (U/mg protein) of purified lnterleukin-4-wild-type (WT) and mutant proteins. Three independent samples 
of each protein were assayed in duplicate. Standard deviations are indicated by bars. The abbrevlations of thc purified.IL4 protein-wild type (WT) 
and. muteins are defined in the text. The activity ofthe Y 1240 protein could not be determined (n .u.): even at I ILg/ml no [3H]thymidine incorpora-
. tion could be measured. · · 
substituted by an acidic side chain seems to be struc~ 
turally intact as iteluted as a singlepeak during HPLC. 
Thus, the functional impairment observed after muta-
tion of this side chain suggests a direct functional role · 
of tyrosine 124 in receptor binding. The chemica:Jly in-
active and therefore possibly interrial residue. tyrosine · 
56 is less likely tobe involved in receptor binding. Thus, 
its SUbstitution by aspartic acid possibly distUrbed the 
folding .of . the protein · with a · concomitant. loss in 
biological activity. This of course has to .be ·established 
by a more thorough comparison of the conformation of 
wild-type and mutant proteins. · 
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